Cargando…

Pharmacological treatments for PTSD: where are we in 2020?

Background: Forty years after the introduction of post-traumatic stress disorder (PTSD) in the third edition of the Diagnostic and Statistical Manual of Mental Disorders, only two selective serotonin reuptake inhibitor antidepressants – sertraline and paroxetine – have received approval for its trea...

Descripción completa

Detalles Bibliográficos
Autor principal:	Bui, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018506/ http://dx.doi.org/10.1080/20008198.2020.1866411

Ejemplares similares

Etiopathogenesis of Graves-Basedow disease; where we are and where we are going
por: Nauman, Janusz
Publicado: (2013)

Neurointervention in the 2020s: Where are We Going?
por: Goyal, Mayank, et al.
Publicado: (2020)

Epilepsy and psychosis– where are we now?
por: Pereira, I., et al.
Publicado: (2021)

A PUBLIC HEALTH APPROACH TO ALZHEIMER’S DISEASE RISK REDUCTION: WHERE WE ARE AND WHERE WE’RE HEADED
por: Omura, John, et al.
Publicado: (2022)

Complex PTSD: assessment and treatment
por: Cloitre, Marylene
Publicado: (2021)

Caffeine in preterm infants: where are we in 2020?
por: Moschino, Laura, et al.
Publicado: (2020)

Implantable Hearing Aids: Where are we in 2020?
por: Banakis Hartl, Renee M., et al.
Publicado: (2020)

The underlying dimensionality of PTSD in the diagnostic and statistical manual of mental disorders: where are we going?
por: Armour, Cherie
Publicado: (2015)

Investigational Anti–Atrial Fibrillation Pharmacology and Mechanisms by Which Antiarrhythmics Terminate the Arrhythmia: Where Are We in 2020?
por: Burashnikov, Alexander
Publicado: (2020)

PTSD: from neurobiology to pharmacological treatments
por: Kelmendi, Benjamin, et al.
Publicado: (2016)

Apathy - where do we find it and how to treat
por: Gomes, R., et al.
Publicado: (2022)

Off-label use of atypical antipsychotics- Where are we?
por: Vaz, R. P., et al.
Publicado: (2023)

Nusinersen and Spinal Muscular Atrophies: Where are we in 2020?
por: Khadilkar, Satish V., et al.
Publicado: (2020)

Policy Series: Family Caregiving Policies: Where We Are Now
por: Nadash, Pamela, et al.
Publicado: (2021)

Music composers and bipolar disorders: Where do we stand?
por: Giannouli, V.
Publicado: (2021)

Suicidality in post-traumatic stress disorder (PTSD) and complex PTSD (CPTSD)
por: Longo, L., et al.
Publicado: (2021)

Articular Cartilage Repair: Where We Have Been, Where We Are Now, and Where We Are Headed
por: Grande, Daniel A., et al.
Publicado: (2013)

Where We Live Matters: Residential Influences on Health and Well-Being
por: Ng, Yee To, et al.
Publicado: (2020)

Epigenetic pathways in PTSD
por: Klengel, T.
Publicado: (2021)

Cancer prevention through weight control—where are we in 2020?
por: Anderson, Annie S., et al.
Publicado: (2020)

The Hearing Aid Effect in the 2020s: Where Do We Stand?
por: Sindi, Abdullah, et al.
Publicado: (2023)

Diversity in modern heart failure trials: Where are we, and where are we going
por: Anaba, Uzoma, et al.
Publicado: (2022)

Maternal sleep position: what do we know where do we go?
por: O’Brien, Louise M, et al.
Publicado: (2015)

EMDR as a treatment option for conditions other than PTSD
por: Abrebak, H., et al.
Publicado: (2023)

Neoadjuvant Treatments for Pancreatic Ductal Adenocarcinoma: Where We Are and Where We Are Going
por: Coppola, Alessandro, et al.
Publicado: (2023)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

“Guidelines Recommendations on the Treatment of Tricuspid Regurgitation. Where Are We and Where Do We Go With Transcatheter Valve Intervention”
por: Vahanian, Alec, et al.
Publicado: (2018)

Where Are We Now? Systematic Review of Surgical Techniques and Outcomes of Uterine Transplantation
por: Escandón, Joseph M., et al.
Publicado: (2021)

Wearable Activity Trackers in the Management of Rheumatic Diseases: Where Are We in 2020?
por: Davergne, Thomas, et al.
Publicado: (2020)

POLYPHARMACY IN ASSISTED LIVING: WHERE ARE WE NOW AND EFFECTIVE APPROACHES TO IMPROVE MEDICATION MANAGEMENT
por: Resnick, Barbara
Publicado: (2022)

The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep
por: Accurso, Vincenzo, et al.
Publicado: (2020)

Development of expert recommendations for the treatment of PTSD with comorbid substance use disorder
por: Roberts, Neil P.
Publicado: (2021)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

TSACO’s Third Anniversary: where we were, where we are, and where we’re going
por: Fabian, Timothy
Publicado: (2019)

Individualized Treatment Strategy for Cutaneous Melanoma: Where Are We Now and Where Are We Going?
por: Zeng, Huihua, et al.
Publicado: (2021)

Obstetric ultrasound: where are we and where are we going?
por: Abramowicz, Jacques S
Publicado: (2021)

Hidradenitis Suppurativa: Where We Are and Where We Are Going
por: Scala, Emanuele, et al.
Publicado: (2021)

The Clusmy Child: Where Are We and Where Are We Going?
por: Hadders-Algra, Mijna, et al.
Publicado: (2003)

Iron health: where are we and where are we going?
por: Gotardo, Glória Ines Beal
Publicado: (2011)

Animal Sentience: Where are We and Where are We Heading?
por: Proctor, Helen
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9pnr0hdbb2n0pomfd9m4re2rai